ERBB3 and neoplasm: In this study we demonstrate that an oligoclonal mixture of anti-ERBB3 mAbs is more effective than individual component mAbs at inhibiting tumor cell growth and suggests an approach for more effective downregulation of ERBB3-dependent signaling.